Site search
2954 results for '' found
BAF_FRontier-1, A First-in-Human, Phase 1 Trial to Assess Safety, Tolerability, and Preliminary Efficacy of LY4152199, a B-cell Activation Factor Receptor [BAFF-R] T-Cell Engager Bispecific Antib
BAF_FRontier-1, A First-in-Human, Phase 1 Trial to Assess Safety, Tolerability, and Preliminary Efficacy of LY4152199, a B-cell Activation Factor Receptor [BAFF-R] T-Cell Engager Bispecific Antib
/
A Proof-of-concept Single-arm clinical trial Of semaglutide after withdrawal of biologic therapy for chronic plaque psoriasis in people with overweight/obesity [PSO-withdraw] (Trial Not Registere
A Proof-of-concept Single-arm clinical trial Of semaglutide after withdrawal of biologic therapy for chronic plaque psoriasis in people with overweight/obesity [PSO-withdraw] (Trial Not Registere
/
Maternity services at Sandringham Hospital
/sandringham/services/maternity-services-at-sandringham-hospital
Menopause Connecting Care Clinic
/services/menopause-connecting-care-clinic
Ngamai_Wilam_GP_Medical_Report___Tests.pdf
Ultra-hyPofractionated stereotactic Radiation therapy for de nOvo Metastatic ProsTate cancer (ACTRN12626000470392)
Ultra-hyPofractionated stereotactic Radiation therapy for de nOvo Metastatic ProsTate cancer (ACTRN12626000470392)
/
A Randomized, Open-label, Phase 2b Study to Compare the Efficacy of DSP107 in Combination with Atezolizumab Versus Fruquintinib in Patients with Advanced Microsatellite Stable Colorectal Cancer (
A Randomized, Open-label, Phase 2b Study to Compare the Efficacy of DSP107 in Combination with Atezolizumab Versus Fruquintinib in Patients with Advanced Microsatellite Stable Colorectal Cancer (
/
A double blind, randomized, placebo-controlled exploratory trial to investigate the efficacy and safety of nerandomilast over 24 months when administered in individuals with interstitial lung abn
A double blind, randomized, placebo-controlled exploratory trial to investigate the efficacy and safety of nerandomilast over 24 months when administered in individuals with interstitial lung abn
/
A double-blind, double-dummy, parallel group, multicenter Phase 3 extension study evaluating the long-term safety and efficacy of 2 doses of remibrutinib in adult participants with moderate to se
A double-blind, double-dummy, parallel group, multicenter Phase 3 extension study evaluating the long-term safety and efficacy of 2 doses of remibrutinib in adult participants with moderate to se
/
A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy, Safety, and Tolerability of Oral PIPE-791 in Subjects with Idiopathic Pulmonary Fibrosis (NCT0
A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy, Safety, and Tolerability of Oral PIPE-791 in Subjects with Idiopathic Pulmonary Fibrosis (NCT0
/